CN104707003B - 治疗高血压、高血脂的中药胶囊 - Google Patents
治疗高血压、高血脂的中药胶囊 Download PDFInfo
- Publication number
- CN104707003B CN104707003B CN201510081343.XA CN201510081343A CN104707003B CN 104707003 B CN104707003 B CN 104707003B CN 201510081343 A CN201510081343 A CN 201510081343A CN 104707003 B CN104707003 B CN 104707003B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- herba
- chinese medicine
- effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010020772 Hypertension Diseases 0.000 title claims abstract description 27
- 208000031226 Hyperlipidaemia Diseases 0.000 title claims abstract description 25
- 239000002775 capsule Substances 0.000 title claims abstract description 22
- 239000003814 drug Substances 0.000 claims abstract description 55
- 210000000582 semen Anatomy 0.000 claims abstract description 24
- 239000000284 extract Substances 0.000 claims abstract description 22
- 235000019198 oils Nutrition 0.000 claims abstract description 13
- 241000736199 Paeonia Species 0.000 claims abstract description 12
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 12
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 12
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 10
- 241001491705 Macrocystis pyrifera Species 0.000 claims abstract description 10
- 241000628997 Flos Species 0.000 claims description 14
- 229940079593 drug Drugs 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 9
- 235000011201 Ginkgo Nutrition 0.000 claims description 7
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 7
- 241000283956 Manis Species 0.000 claims description 7
- 241000001350 Pterygiella tenuisecta Species 0.000 claims description 7
- 241000519950 Chara fragilis Species 0.000 claims description 6
- 229920002472 Starch Polymers 0.000 claims description 6
- 235000019698 starch Nutrition 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 3
- 244000194101 Ginkgo biloba Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 40
- 230000017531 blood circulation Effects 0.000 abstract description 17
- 208000035150 Hypercholesterolemia Diseases 0.000 abstract description 4
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 3
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 3
- 230000001225 therapeutic effect Effects 0.000 abstract description 3
- 230000000857 drug effect Effects 0.000 abstract description 2
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 2
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 230000003449 preventive effect Effects 0.000 abstract description 2
- 210000004369 blood Anatomy 0.000 description 41
- 239000008280 blood Substances 0.000 description 41
- 210000004185 liver Anatomy 0.000 description 22
- 208000002193 Pain Diseases 0.000 description 20
- 230000006870 function Effects 0.000 description 19
- 230000036407 pain Effects 0.000 description 19
- 239000000796 flavoring agent Substances 0.000 description 18
- 235000019634 flavors Nutrition 0.000 description 18
- 210000004072 lung Anatomy 0.000 description 17
- 206010011224 Cough Diseases 0.000 description 16
- 230000001737 promoting effect Effects 0.000 description 16
- 210000003734 kidney Anatomy 0.000 description 15
- 206010062717 Increased upper airway secretion Diseases 0.000 description 12
- 230000007812 deficiency Effects 0.000 description 12
- 208000026435 phlegm Diseases 0.000 description 12
- 239000003921 oil Substances 0.000 description 10
- 210000002784 stomach Anatomy 0.000 description 10
- 206010000087 Abdominal pain upper Diseases 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 9
- 230000001105 regulatory effect Effects 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 239000003925 fat Substances 0.000 description 8
- 235000019197 fats Nutrition 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 230000000994 depressogenic effect Effects 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000014674 injury Diseases 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 230000008736 traumatic injury Effects 0.000 description 7
- 208000006820 Arthralgia Diseases 0.000 description 6
- 241000218628 Ginkgo Species 0.000 description 6
- 206010047700 Vomiting Diseases 0.000 description 6
- 210000000038 chest Anatomy 0.000 description 6
- 238000009826 distribution Methods 0.000 description 6
- 231100000252 nontoxic Toxicity 0.000 description 6
- 230000003000 nontoxic effect Effects 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 230000008673 vomiting Effects 0.000 description 6
- 238000010792 warming Methods 0.000 description 6
- 208000019255 Menstrual disease Diseases 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- 208000006673 asthma Diseases 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 5
- 208000002173 dizziness Diseases 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 5
- 230000004438 eyesight Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 206010000077 Abdominal mass Diseases 0.000 description 4
- 244000025254 Cannabis sativa Species 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010036790 Productive cough Diseases 0.000 description 4
- 208000025747 Rheumatic disease Diseases 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 239000003172 expectorant agent Substances 0.000 description 4
- 230000003419 expectorant effect Effects 0.000 description 4
- 208000006454 hepatitis Diseases 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 230000000552 rheumatic effect Effects 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 4
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 3
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 206010002383 Angina Pectoris Diseases 0.000 description 3
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 3
- 206010010071 Coma Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 206010011878 Deafness Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 229940074393 chlorogenic acid Drugs 0.000 description 3
- 235000001368 chlorogenic acid Nutrition 0.000 description 3
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 3
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 3
- 208000013116 chronic cough Diseases 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 3
- 231100000895 deafness Toxicity 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 208000016354 hearing loss disease Diseases 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 210000003802 sputum Anatomy 0.000 description 3
- 208000024794 sputum Diseases 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 208000004371 toothache Diseases 0.000 description 3
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 2
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 2
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 206010008909 Chronic Hepatitis Diseases 0.000 description 2
- 244000037364 Cinnamomum aromaticum Species 0.000 description 2
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010057315 Daydreaming Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 2
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 206010039897 Sedation Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 description 2
- 235000010081 allicin Nutrition 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 235000004883 caffeic acid Nutrition 0.000 description 2
- 229940074360 caffeic acid Drugs 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- MDZKJHQSJHYOHJ-UHFFFAOYSA-N crataegolic acid Natural products C1C(O)C(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MDZKJHQSJHYOHJ-UHFFFAOYSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 2
- 235000012734 epicatechin Nutrition 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 229930182486 flavonoid glycoside Natural products 0.000 description 2
- 150000002215 flavonoids Chemical group 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- MDZKJHQSJHYOHJ-LLICELPBSA-N maslinic acid Chemical compound C1[C@@H](O)[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MDZKJHQSJHYOHJ-LLICELPBSA-N 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000014593 oils and fats Nutrition 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 2
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 2
- 230000036280 sedation Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- UUTKICFRNVKFRG-WDSKDSINSA-N (4R)-3-[oxo-[(2S)-5-oxo-2-pyrrolidinyl]methyl]-4-thiazolidinecarboxylic acid Chemical compound OC(=O)[C@@H]1CSCN1C(=O)[C@H]1NC(=O)CC1 UUTKICFRNVKFRG-WDSKDSINSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- 208000006678 Abdominal Neoplasms Diseases 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 101100025924 Caenorhabditis elegans gei-8 gene Proteins 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 235000002555 Citrus medica var sarcodactylis Nutrition 0.000 description 1
- 240000007126 Citrus medica var. sarcodactylis Species 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 201000006306 Cor pulmonale Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010015137 Eructation Diseases 0.000 description 1
- 244000268590 Euryale ferox Species 0.000 description 1
- 235000006487 Euryale ferox Nutrition 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 206010018833 Haematocoele Diseases 0.000 description 1
- 208000005873 Hematocele Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 241000607292 Maguireothamnus speciosus Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 208000033240 Progressive symmetric erythrokeratodermia Diseases 0.000 description 1
- 206010037596 Pyelonephritis Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 206010048214 Xanthoma Diseases 0.000 description 1
- 206010048215 Xanthomatosis Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000037006 agalactosis Effects 0.000 description 1
- 150000008126 allyl sulfides Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000002300 anti-fibrosis Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000003930 cognitive ability Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- -1 dioxygen flavonoid glycoside Chemical class 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000007946 flavonol Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 201000004920 hematocele of tunica vaginalis testis Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000003516 hyperlipidaemic effect Effects 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 208000004141 microcephaly Diseases 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 208000010553 multiple abscesses Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000008517 radix Trichosanthis Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 208000012201 sexual and gender identity disease Diseases 0.000 description 1
- 208000015891 sexual disease Diseases 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 210000003371 toe Anatomy 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 150000003648 triterpenes Chemical group 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000002918 waste heat Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及中药,特别一种治疗高血压、高血脂的中药胶囊。胶囊内的内容物包括:中药提取物40-45份、梅花冰片5-7份、石菖蒲8-10份、百合8-12份、茖葱4-5份、牡丹籽油20份、山楂干8-10份、决明子8-10份、巨藻4-8份、大乌金草5-7份、黄花倒水莲5-7份、刺黄柏叶4-8份、薤白油3-5份。本发明具有较好的改善血液循环、防治动脉硬化的作用,对心脑血管疾病具有较好的防治作用。对治疗高血压、高血脂和高胆固醇及其并发症都有药效快、疗效好、无毒副作用等显著的疗效,其有效率高达100%。
Description
(一) 技术领域
本发明涉及药品,特别一种治疗高血压、高血脂的中药胶囊。
(二) 背景技术
据调查,我国高血压、高血脂的患病率在20%以上。高血压、高血脂患者初期通常没有任何不适感觉,一旦发病很可能造成伤残或死亡。高血脂引起的动脉粥样硬化对身体的损害是隐匿、逐渐、进行性和全身性的。随着病情发展,会出现头晕目眩、胸闷气短、心慌心悸、口角歪斜、肢体麻木、黄色瘤等,甚至会引发高血压、糖尿病、胆结石、胰腺炎、男性功能障碍、心脑血管等疾病。另外,高血脂症常常伴随着肥胖。
目前为止,还没有根治高血压、高血脂的方法,患者一般都需要终生服药。长期服用西药毒副作用不容忽视。中医力求病因,有时可能取得意想不到的效果,但目前能同时治疗高血压、高血脂的药物非常少见。
(三) 发明内容
本发明为了弥补现有技术的不足,提供了一种效果好、效果持久的治疗高血压、高血脂的中药胶囊。
本发明是通过如下技术方案实现的:
一种治疗高血压、高血脂的中药胶囊,其特殊之处在于:胶囊内的内容物包括:中药提取物40-45份、梅花冰片5-7份、石菖蒲8-10份、百合8-12份、茖葱4-5份、牡丹籽油20份、山楂干8-10份、决明子8-10份、巨藻4-8份、大乌金草5-7份、黄花倒水莲5-7份、刺黄柏叶4-8份、薤白油3-5份,
中药提取物由以下重量份数的原料药提取制成:茺蔚子5-10份、穿山甲5-8份、葫芦巴8-10份、石斛4-8份、旋覆花7份、玫瑰花10-12份、荔枝核5-8份、小伸筋草6-9份、木半夏根9-12份、芦根5-9份、沙糖根4-8份、鱼草7-9份、波罗蜜树液6-8份、草柏枝7-11份、荩草7-10份、柔毛水杨梅6-9份、埃蕾6-10份、桔梗芦头4-9份、桄榔子5-10份、红花醡浆草7-10份、地骷髅7-9份、银杏叶8份、桂枝5-7份。
一种根据所述的治疗高血压、高血脂的中药胶囊的制备方法,包括以下步骤:首先制备中药提取物,然后将中药提取物、梅花冰片、石菖蒲、百合、茖葱、山楂干、决明子、巨藻、大乌金草、黄花倒水莲、刺黄柏叶粉碎,配以牡丹籽油、薤白油制备胶囊。
本发明的治疗高血压、高血脂的中药胶囊的制备方法,中药提取物的制备过程:将称得的各原料粉碎,过 40 目筛后,煎煮,趁热滤过,所得上清液浓缩至相对密度为1.30-1.35 的清膏,干燥得到中药提取物。
使用方法:每日早晚各一次,每次3-4粒,每粒内容物2g。
下面为本发明中各药材的功能及作用:
薤白油所含大蒜辣素的主要成分为硫化丙烯,有降脂作用,且性味辛温,能温阳散结,可用于治疗高胆固醇和高血脂症;薤白所含的大蒜辣素能杀菌消炎,对多种细菌有明显的抑制作用,对感染疾病有治疗效果。薤白所含的特殊香气和辣味,能促进消化功能,增加食欲,还可加强血液循环,起到利尿祛湿的作用。
牡丹籽油是迄今为止所发现的油脂中最适合人体营养的油脂,是所有食用油总营养价值最高,成份结构最合理的。牡丹籽油中含有丰富的亚麻酸,而亚麻酸具有增强自身免疫力、降血脂和降血压、预防糖尿病、防治癌症、清理血中有害物质和防治心脏病、提神健脑,增强注意力和记忆力、及美容的功效。饮酒前,内服少许牡丹籽油,还可迅速保护胃、肠和肝功能。
葫芦巴:苦,温,归肝,肾经。功效: 温肾阳,逐寒湿。主治: 适用于肾阳不足而有寒湿之证。如肾脏虚冷,腹胁胀满;寒湿脚气,腿膝冷痛无力;寒疝,少腹连睾丸作痛。
石斛:甘,微寒,归胃,肾经。功效: 养阴清热,益胃生津。主治:(1)用于肝肾阴虚,腰膝酸软,虚热不退,以及目暗不明,视物不清等证。(2)热病津伤,烦热口渴,舌绛苔黑等症及胃阴不足,舌红口干,食少干呕等。
旋覆花:苦、辛、咸,微温,归肺、脾、大肠经。功效: 降气止呕,化痰止咳。主治:(1)本品性善下降,能入脾胃,善于降胃气而止呕意,主要用于脾胃虚寒或痰湿内聚,胃失和降所致的噫气呕吐,常与代赭石、半夏、生姜等品配伍。(2)旋覆花能入肺经,可化痰饮、下肺气,适用于痰壅气逆及痰饮蓄结所致的喘咳痰多之症,可与桑白皮、甜葶苈、陈皮、半夏等品配伍;如有表证者,当配荆芥、细辛、前胡、半夏等同用。
玫瑰花:甘、微苦,温,归肝、脾经。功效:疏肝理气,和血散瘀。主治:(1)本品气味清香,善能疏肝理气而解郁,主要适用于肝气郁结、胸闷胁痛及肝胃不和、脘腹胀痛、嗳气则舒等症,可配合白残花、佛手片等药同用;(2)对于经前乳房胀痛可配青皮、橘叶、川楝子等同用。(3)本品又入血分,具有和血散瘀作用,治疗月经不调,以及损伤瘀血等症,可配合当归、川芎、泽兰 叶等药同用。
荔枝核:辛,温,归肝经。功效:疏肝理气,散结止痛。主治:(1)本品药性辛温,专入肝经,功能疏肝理气、散结止痛,为治疗肝经寒凝气滞所致的疝气,睪丸肿痛的常用要药,常与小茴香、吴茱萸、橘核等药配合应用。(2)本品疏肝理气止痛,用于肝气郁滞的胃脘疼痛,可与木香同用;(3)若用肝郁气滞的痛经及产后腹痛,可配香附同用。
小伸筋草:性味归经:云南中草药》:“苦涩,温。”入肾,胃二经。功用主治-小伸筋草的功效:①《云南中草药》;疏经活络,温肾止痛。治风湿,周身酸冷,胃寒痛。
木半夏根:功效分类:活血药;补益药性味:①《本草拾遗》:"平,无毒。" ②《四川中药志》:"性微温,味淡涩,无毒。"功用主治:跌打损伤;虚弱劳损;泻痢;肝炎;恶疮疥癞。①《本草拾遗》:"根皮煎汤洗恶疮疥。"②《四川中药志》:"活血,行气,补虚损。治跌打损伤及痔疮。"
芦根:性味:甘,寒。归经:归肺、胃经。功效:清热泻火,生津止渴,除烦,止呕,利尿。主治:用于热病烦渴,肺热燥咳,内热消渴,疮疡肿毒。
沙糖根,为茜草科植物小头凉喉茶的全株。生于山野疏林灌木丛中。可入药。具有散寒通络,养血,截疟的功效。
鱼草: 归经:肺经.功效:祛痰;止咳;平喘。主治:咳嗽;痰多;胸闷。功效分类:宣肺药;祛痰药。
波罗蜜树液:性味:淡;涩;性平。主治:疮疖红肿或疮疖红肿引起的淋巴结炎。
草柏枝:清热解毒,养心安神,止痛。用于心脏衰弱,心悸,咳嗽,痰中带血,咽喉肿痛,骨折;外用治蛇、犬咬伤。
茖葱:性味:《千金·食治》:"辛,微温,无毒。"归经:肺经。功能主治:散瘀;止血;解毒。主跌打损伤;血瘀肿痛;衄血;疮痈肿痛。
荩草:性味:①《本经》:"味苦,平。"②《别录》:"无毒。"功用主治:止咳、定喘,杀虫。
柔毛水杨梅:苦、辛;性寒。归经:脾;肾;肝经.功效:补肾平肝,活血消肿.功效分类:补益药.主治:头晕目眩;小儿惊风;阳痿;遗精;虚劳咳嗽;风湿痹痛;月经不调;疮疡肿痛;跌打损伤.
埃蕾:性味:苦,寒。功能:清热解毒。主治:肝炎,胆囊炎,头痛,发热,牙痛,扁桃体炎。
桔梗芦头:功用主治:吐上膈风热痰实,生研末,白汤调服一钱,探吐。
桄榔子:性味①《开宝本草》:" 味苦,乎,无毒。"②《本草汇言》:" 味苦,气温,无毒。"功用主治:①《开宝本草》:"主宿血。"②《本草汇言》:"破宿食、积血。磨汁治妇人产后儿枕血瘕诸疼,及心胃寒疼。"
红花醡浆草:性味归经:酸,寒。功能主治:清热解毒,散瘀消肿,调经。用于肾盂肾炎,痢疾,咽炎,牙痛,月经不调,白带;外用治毒蛇咬伤,跌打损伤,烧烫伤。
地骷髅的功效宣肺化痰,消食,利水。治咳嗽多痰,食积气滞,脘腹痞闷胀痛,水肿喘满,噤口痢疾。
百合:性味归经:百合味苦,性微寒。入心、肺经。功能主治:养阴润肺,清心安神。用于阴虚久咳,痰中带血,虚烦惊悸,失眠多梦,精神恍惚。具有养阴润肺止咳功效,用于肺阴虚的燥热咳嗽,如百花膏。治肺虚久咳,劳嗽咯血,如百合固金汤。具有清心安神功效,用于热病余热未清,虚烦惊悸,失眠多梦等。药用时煎服,10~30g。清心宜生用,润肺蜜炙用。
石菖蒲:功能主治:化湿开胃,开窍豁痰,醒神益智。用于脘痞不饥,噤口下痢,神昏癫痫,健忘耳聋。理气,活血,散风,去湿。治癫痫,痰厥,热病神昏,健忘,气闭耳聋,心胸烦闷,胃痛,腹痛,风寒湿痹,痈疽肿毒,跌打损伤。
山楂干能防治心血管疾病,具有扩张血管、强心、增加冠脉血流量、改善心脏活力、兴奋中枢神经系统、降低血压和胆固醇、软化血管及利尿和镇静作用; 防治动脉硬化,防衰老、抗癌的作用
山楂干含绿原酸(chlorogenic acid)、咖啡酸、山楂酸( crataegolic acid)、齐菊果酸、槲皮素、熊果酸、齐墩果酸、金丝桃甙(hyperin)、表儿茶精(epicatechin)等。为蔷薇科植物山楂、山里红或野山楂的果实。主产于山东、河南、江苏、浙江等地。山楂干的主要成分是黄酮类物质, 对心血管系统有明显的药理作用。 从山楂中分离的黄酮成分有30 余种, 主要有含碳键的黄酮苷类、黄酮醇及其苷类、双氧黄酮苷类、聚合黄酮类。另一类较为重要的成分是三萜类物质,有强心、增加冠脉血流、改善血流循环等重要作用。此外, 山楂中含有机酸如氯原酸、咖啡酸及鞣质、鞣酐、表儿茶酚、胆碱、乙酰胆碱、β 谷甾醇、胡萝卜素及大量Vit C 等。性味归经:味酸、甘,性微温。归脾、胃、肝经。功用主治:开胃消食、化滞消积、活血散瘀、化痰行气。用于肉食滞积、症瘕积聚、腹胀痞满、瘀阻腹痛、痰饮、泄泻、肠风下血等。
决明子,中药名。是豆科植物决明或小决明的干燥成熟种子,以其有明目之功而名之。秋季采收成熟果实,晒干,打下种子,除去杂质。决明子味苦、甘、咸,性微寒,入肝、肾、大肠经;润肠通便,降脂明目,治疗便秘及高血脂,高血压。清肝明目,利水通便,有缓泻作用,降血压降血脂。
银杏叶:性味:甘、苦、涩,平。归经:归心、肺经。功效:活血化瘀,通络止痛,敛肺平喘,化浊降脂。主治:用于瘀血阻络,胸痹心痛,中风偏瘫,肺虚咳喘,高脂血症。
桂枝:其性味辛、甘,入肝、肾、脾,是主治里寒常用的温里药,具有补元阳、通血脉、暖脾胃之功效,常与补肝肾药、补气血药配伍,治疗肾阳不足、命门火衰、肢冷脉微,与其它温里药配伍治疗脘腹冷痛、寒痹腰痛,具有明显的镇痛和抗癌防癌的作用。现有的各种驱风油类药物如清凉油、风湿油等皆含有桂油成分。主治麻疯病的“苯丙矾”其主要成分即桂油,肉桂的其它副产品如桂枝、桂子、桂丁、桂盅等都有不同的药理作用,在中药中广为应用。
丹参:性能:味苦,性微寒。能活血化瘀,凉血,安神。能扩张冠状动脉,增加冠脉流量,改善心肌缺血、梗塞和心脏功能,调节心律,并能扩张外周血管,改善微循环;能提高机体耐缺氧能力;有抗凝血,促进纤溶,抑制血小板凝聚,抑制血栓形成的作用;能降低血脂,抑制冠脉粥样硬化形成;能抑制或减轻肝细胞变性、坏死及炎症反应,促进肝细胞再生,并有抗纤维化作用;用途:用于血瘀所致月经不调、痛经、经闭,产后瘀滞腹痛;冠心病心绞痛,动脉粥样硬化;慢性肝炎、肝硬化,腹腔包块或肿瘤;慢性肺心病,支气管哮喘;血不养心或心火偏亢,心悸不安,心烦失眠。
穿山甲:性味:味咸;性微寒。归经:肝;胃经。功能主治:活血散结;通经下乳;消痈溃坚。主血瘀经闭;症瘕;风湿痹痛;乳汁不下;痈肿;瘰疬。
茺蔚子:性味:辛、苦,微寒。归经:归心包、肝经。功效:活血调经,清肝明目。主治:用于月经不调,经闭痛经,目赤翳障,头晕胀痛。
梅花冰片:辛、苦、凉。人心、肺经。开窍醒神;散热止痛;明目去翳。主中风口噤;热病神昏;惊痫痰迷;气闭耳聋;目赤翳膜;喉痹;口疮;痈肿;痔疮;蛲虫病。其药理作用:具有明显的镇痛和镇静作用,有促进雪旺细胞生长和分裂的作用,具有抗炎作用,对小鼠炎症反应、大鼠蛋清性足趾肿胀均有显著性抑制作用,具有抗菌作用,在中枢神经有较高浓度和较长的停留时间,在血液中能较长时间维持较高浓度,由肝、肾消除较快,不易蓄积。
大乌金草:性味:辛;温。功能主治:温肺祛痰;祛风除湿;理气止痛。主风寒咳嗽; 风湿性关节痛;胃痛;腹痛;牙痛。
黄花倒水莲:性味:甘;微苦;性平。归经:肝;肾;脾经.功能主治:补益,强壮,祛湿,散瘀。治虚弱虚肿,急慢性肝炎,腰腿酸疼,跌打损伤。
巨藻:功效:缓解心绞痛。主治:高胆固醇;高血压及动脉硬化症;气管炎;哮喘等。
走游草,常绿或半常绿藤本,小枝和叶柄有刚毛,伞形花序腋生,浆果呈圆球状倒卵形,生于温暖、阴湿的山区石崖上或林中,主要分布我国中部及西南地区。有祛风,除湿,行血,解毒功效,能治头痛、身痛、风湿痹痛,流注,疮毒。
刺黄柏叶:主治肺结核。
本发明的有益效果是:草柏枝、百合安心养神;葫芦巴、石斛、柔毛水杨梅滋补肝肾;玫瑰花、荔枝核疏肝理气;菟丝子、沙苑子、芡实养肝明目;小叶爱楠、井边草、玉龙鞭、地瓜果、天花粉、香薷清热消肿;木半夏根、沙糖根、茺蔚子、穿山甲活血化瘀,银杏叶、桂枝通脉止痛,山楂干、决明子、巨藻降血压血脂,梅花冰片、石菖蒲开窍醒脑,本发明把薤白油和牡丹籽油按一定配比结合起来制成的保健药品既可以有效的预防和治疗高血压和高血脂,又可以起到强身健体,预防其他疾病的功效。上述诸药配伍,具有降脂降压、温阳散结,增加食欲,加强血液循、活血化瘀、滋补肝肾、疏肝理气、降低血压血脂、醒脑开窍的功效。本发明具有较好的改善血液循环、防治动脉硬化的作用,对心脑血管疾病具有较好的防治作用。对治疗高血压、高血脂和高胆固醇及其并发症都有药效快、疗效好、无毒副作用等显著的疗效,其有效率高达100%。
(四) 具体实施方式
实施例1
本实施例的治疗高血压、高血脂的中药胶囊,制备方法:
(1)中药提取物由以下重量份数的原料药提取制成:茺蔚子10份、穿山甲8份、葫芦巴10份、石斛6份、旋覆花7份、玫瑰花10份、荔枝核5份、小伸筋草8份、木半夏根12份、芦根5份、沙糖根6份、鱼草7份、波罗蜜树液8份、草柏枝8份、荩草7份、柔毛水杨梅6份、埃蕾6份、桔梗芦头9份、桄榔子10份、红花醡浆草8份、地骷髅7份、银杏叶8份、桂枝5份,粉碎,过40目筛后,煎煮,趁热滤过,所得上清液浓缩至相对密度为1.30-1.35(50℃) 的清膏,干燥得到中药提取物。
(2)将中药提取物45份、梅花冰片5份、石菖蒲8份、百合12份、茖葱4份、山楂干8份、决明子8份、巨藻4份、大乌金草5份、黄花倒水莲5份、刺黄柏叶4份粉碎,配以牡丹籽油20份、薤白油3份制备胶囊。
使用方法:每日早晚各一次,每次3-4粒,每粒内容物2g。
实施例2
本实施例的治疗高血压、高血脂的中药胶囊,制备方法:
(1)中药提取物由以下重量份数的原料药提取制成:茺蔚子9份、穿山甲5份、葫芦巴8份、石斛4份、旋覆花7份、玫瑰花12份、荔枝核7份、小伸筋草6份、木半夏根10份、芦根9份、沙糖根8份、鱼草8份、波罗蜜树液6份、草柏枝11份、荩草10份、柔毛水杨梅8份、埃蕾10份、桔梗芦头4份、桄榔子5份、红花醡浆草10份、地骷髅9份、银杏叶8份、桂枝6份,粉碎,过 40 目筛后,煎煮,趁热滤过,所得上清液浓缩至相对密度为1.30-1.35(50℃) 的清膏,干燥得到中药提取物。
(2)将中药提取物40份、梅花冰片7份、石菖蒲9份、百合8份、茖葱5份、山楂干10份、决明子10份、巨藻8份、大乌金草7份、黄花倒水莲7份、刺黄柏叶8份粉碎,配以牡丹籽油20份、薤白油5份制备胶囊。
使用方法:每日早晚各一次,每次3-4粒,每粒内容物2g。
实施例3
本实施例的治疗高血压、高血脂的中药胶囊,制备方法:
(1)中药提取物由以下重量份数的原料药提取制成:茺蔚子5份、穿山甲7份、葫芦巴9份、石斛8份、旋覆花7份、玫瑰花11份、荔枝核8份、小伸筋草9份、木半夏根9份、芦根7份、沙糖根4份、鱼草9份、波罗蜜树液8份、草柏枝7份、荩草8份、柔毛水杨梅9份、埃蕾8份、桔梗芦头6份、桄榔子7份、红花醡浆草7份、地骷髅8份、银杏叶8份、桂枝7份,粉碎,过 40 目筛后,煎煮,趁热滤过,所得上清液浓缩至相对密度为1.30-1.35 (50℃)的清膏,干燥得到中药提取物。
(2)将中药提取物42份、梅花冰片6份、石菖蒲10份、百合11份、茖葱5份、山楂干9份、决明子9份、巨藻7份、大乌金草6份、黄花倒水莲6份、刺黄柏叶7份粉碎,配以牡丹籽油20份、薤白油4份制备胶囊。
使用方法:每日早晚各一次,每次3-4粒,每粒内容物2g。
实施例4临床观察
(1)一般资料
本发明人于2008年至今对400例门诊患者进行临床观察治疗,年龄35到75岁不等,总有效率为100%,治愈率高达94.7%。
(2)治疗方法:每日早晚各一次,每次3-4粒,每粒内容物2g,3-5天为一疗程。
(3)疗效评定标准
治愈:症状体征完全消失;
有效:症状体征较前减轻;
无效:症状体征与治疗前无改善。
(5)典型病例:
韩某某,女,67岁,菏泽曹县人。2010 年8月精神萎靡、注意力不集中、记忆力下降,经诊断为高血压,2010年8月开始服用本发明药物,服用2天后注意力集中,精神变好,继续服用3个疗程后,停药,至今未复发。
张某,男,40岁,山东聊城人,患有高血压、高血脂,经常出现头悬目眩,心烦不寐、口苦肢麻的症状,2012年开始服用本发明中药,1个疗程后症状减轻大大减轻,精神恢复,继续服用2个疗程后停药。
郭某,女,55岁,济南人, 2012年开始出现头晕、无力、胸闷、视线模糊等状况,有时还伴有头痛、恶心症状,经诊断患有高血压,随服用本发明中药,1个疗程后症状减轻,继续服用3个疗程后停药,至今未复发。
Claims (3)
1.一种治疗高血压、高血脂的中药胶囊,其特征在于:胶囊内的内容物由以下原料组成:中药提取物40-45份、梅花冰片5-7份、石菖蒲8-10份、百合8-12份、茖葱4-5份、牡丹籽油20份、山楂干8-10份、决明子8-10份、巨藻4-8份、大乌金草5-7份、黄花倒水莲5-7份、刺黄柏叶4-8份、薤白油3-5份,
中药提取物由以下重量份数的原料药提取制成:茺蔚子5-10份、穿山甲5-8份、葫芦巴8-10份、石斛4-8份、旋覆花7份、玫瑰花10-12份、荔枝核5-8份、小伸筋草6-9份、木半夏根9-12份、芦根5-9份、沙糖根4-8份、鱼草7-9份、波罗蜜树液6-8份、草柏枝7-11份、荩草7-10份、柔毛水杨梅6-9份、埃蕾6-10份、桔梗芦头4-9份、桄榔子5-10份、红花醡浆草7-10份、地骷髅7-9份、银杏叶8份、桂枝5-7份。
2.一种根据权利要求1所述的治疗高血压、高血脂的中药胶囊的制备方法,其特征在于:包括以下步骤:首先制备中药提取物,然后将中药提取物、梅花冰片、石菖蒲、百合、茖葱、山楂干、决明子、巨藻、大乌金草、黄花倒水莲、刺黄柏叶粉碎,配以牡丹籽油、薤白油制备胶囊。
3.根据权利要求2所述的治疗高血压、高血脂的中药胶囊的制备方法,其特征在于:中药提取物的制备过程:将称得的各原料粉碎,过 40 目筛后,煎煮,趁热滤过,所得上清液浓缩至相对密度为1.30-1.35 的清膏,干燥得到中药提取物。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510081343.XA CN104707003B (zh) | 2015-02-15 | 2015-02-15 | 治疗高血压、高血脂的中药胶囊 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510081343.XA CN104707003B (zh) | 2015-02-15 | 2015-02-15 | 治疗高血压、高血脂的中药胶囊 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104707003A CN104707003A (zh) | 2015-06-17 |
| CN104707003B true CN104707003B (zh) | 2015-10-07 |
Family
ID=53407047
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510081343.XA Active CN104707003B (zh) | 2015-02-15 | 2015-02-15 | 治疗高血压、高血脂的中药胶囊 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104707003B (zh) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103751566A (zh) * | 2013-12-24 | 2014-04-30 | 申天顺 | 一种治疗高血压的中药配方 |
-
2015
- 2015-02-15 CN CN201510081343.XA patent/CN104707003B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN104707003A (zh) | 2015-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103520572B (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
| CN104873947A (zh) | 用于治疗狗急性上消化道出血的药物组合物及其制备方法 | |
| CN105688160A (zh) | 一种中药组合物在制备治疗日光性皮炎药物中的用途 | |
| CN104666579A (zh) | 一种治疗膝关节滑膜炎的中药组合物及其制备方法 | |
| CN103933509B (zh) | 用于治疗淡水鱼水霉病的药物及其制备方法 | |
| CN103301267B (zh) | 一种治疗高血压和/或动脉粥样硬化的中药组合物及应用 | |
| CN103041256B (zh) | 一种治疗小儿反复呼吸道感染的中药制剂 | |
| CN105194421A (zh) | 一种夏枯草降血脂保健口服液及其制备方法 | |
| CN105028772B (zh) | 用于降血脂的保健养生茶及其制备方法 | |
| CN103041257B (zh) | 治疗小儿发热高烧呼吸道感染的中药制剂 | |
| CN102178781B (zh) | 一种治疗阴囊湿疹的中药组合物及其制备方法 | |
| CN101518594A (zh) | 一种抗肿瘤及增强免疫力的中药制剂及其制备方法 | |
| CN103933405A (zh) | 用于治疗气血两虚型烧伤的药物组合物及其制备方法 | |
| CN105125677A (zh) | 治疗原发性三叉神经痛的制剂丸剂的制备方法 | |
| CN104707004A (zh) | 降血压的药物 | |
| CN104666999A (zh) | 一种降血压的中药配方 | |
| CN104707003B (zh) | 治疗高血压、高血脂的中药胶囊 | |
| CN105381220A (zh) | 一种明目降脂的菟丝子保健茶 | |
| CN104983886A (zh) | 治疗便秘的中药制剂及制备方法 | |
| CN104173973A (zh) | 一种治疗痢疾的口服液及其制备方法 | |
| CN103417836B (zh) | 治疗肿瘤的中药组合物及其制备方法 | |
| CN108721540A (zh) | 治疗肝癌六种情况的中药配方 | |
| CN104666998A (zh) | 一种用于治疗高血压的中药组合物 | |
| CN105770760A (zh) | 主治胃溃疡的制剂及其制备方法 | |
| CN106039075A (zh) | 一种治疗肺胃蕴热型慢性咽炎的中药组合物及方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| PP01 | Preservation of patent right |
Effective date of registration: 20160803 Granted publication date: 20151007 |
|
| RINS | Preservation of patent right or utility model and its discharge | ||
| PD01 | Discharge of preservation of patent |
Date of cancellation: 20170203 Granted publication date: 20151007 |
|
| PP01 | Preservation of patent right |
Effective date of registration: 20170206 Granted publication date: 20151007 |
|
| RINS | Preservation of patent right or utility model and its discharge | ||
| PD01 | Discharge of preservation of patent | ||
| PD01 | Discharge of preservation of patent |
Date of cancellation: 20170806 Granted publication date: 20151007 |